AHMED MAHIUDDIN (Sr. VP and CSO) sold 7.7% of their position (20K shares) of Y-MABS THERAPEUTICS, INC. on the open market
Open‑market sale worth $783.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/13/2020ACC: 0001104659-20-060887
Officer· Sr. VP and CSO
Since Jan 2020
-20K
Net shares
Net seller
$783.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
20K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−20K
Price / share
$39.19
Trade value
$783.78K
% of position
7.7%
5/12/2020
260K→240K
Total
Net shares
−20K
Net value
-$783.78K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/12/2020 | S · Sale | −20K | $39.19 | $783.78K | 7.7% | 260K | 240K |
| Total | −20K | -$783.78K | ||||||
Derivative Transactions0
No derivative transactions reported